TDP-43 redistribution is an early event in sporadic amyotrophic lateral sclerosis

Brain Pathology

Volumn 20, Issue 2, 2010, Pages 351-360

  Giordana, Maria Teresa ^a   Piccinini, Marco ^a   Grifoni, Silvia ^a   De Marco, Giovanni ^a   Vercellino, Marco ^a   Magistrello, Michela ^a   Pellerino, Alessia ^a   Buccinnà, Barbara ^a   Lupino, Elisa ^a   Rinaudo, Maria Teresa ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

ALS; Biochemistry; Cell counting; Immunohistochemistry; TDP 43; Ubiquitin

Indexed keywords

TAR DNA BINDING PROTEIN; UBIQUITIN;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CELL INCLUSION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOPLASM; DENTATE GYRUS; DISEASE COURSE; FEMALE; FRONTAL CORTEX; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; MOTONEURON; NERVE CELL; NERVE CELL DEGENERATION; PROTEIN LOCALIZATION; QUANTITATIVE ANALYSIS; SOLUBILITY; SPINAL CORD MOTONEURON; SPINAL CORD VENTRAL HORN; TEMPORAL CORTEX; UBIQUITINATION;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; CELL COUNT; CYTOPLASM; DISEASE PROGRESSION; DNA-BINDING PROTEINS; FEMALE; FRONTAL LOBE; HIPPOCAMPUS; HUMANS; MALE; MIDDLE AGED; MOTOR NEURONS; NEURONS; SPINAL CORD; TEMPORAL LOBE; TIME FACTORS; UBIQUITIN; UBIQUITINATION;

EID: 75949105684     PISSN: 10156305     EISSN: 17503639     Source Type: Journal    
DOI: 10.1111/j.1750-3639.2009.00284.x     Document Type: Article

References (42)

1. André P, Groettrup M, Klenerman P, De Giuli R, Booth BL Jr., Cerundolo V et al (1998) An inhibitor of HIV-1 protease modulates proteasome activity, antigen presentation, and t cell responses. Proc Natl Acad Sci USA 95 : 13120 13124.
2. Arai T, Hasegawa M, Akiyama H, Ikeda K, Nonaka T, Mori H et al (2006) TDP-43 is a component of ubiquitin-positive inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem Biophys Res Commun 351 : 602 611.
3. Bjerrum OJ, Schafer-Nielsen C (1986) Buffer system and transfer parameters for semi-dry electroblotting with a horizontal apparatus. In : Electrophoresis'68. MJ Dunn (ed.), pp. 315 327. VCH : Weinheim.
4. Brandmeir NJ, Geser F, Kwong LK, Zimmerman E, Qian J, Lee VM, Trojanowski JQ (2007) Severe subcortical TDP-43 pathology in sporadic frontotemporal lobar degeneration with motor neuron disease. Acta Neuropathol 115 : 147 149.
5. Brooks BR, Miller RG, Swash M, Munsat TL, World Federation of Neurology Research Group on Motor Neuron Diseases (2000) El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 1 : 293 299.
6. Buratti E, Dörk T, Zuccato E, Pagani F, Romano M, Baralle FE (2001) Nuclear factor TDP-43 and SR proteins promote in vitro and in vivo CFTR exon skipping. EMBO J 20 : 1774 1784.
7. Cairns NJ, Neumann M, Bigio EH, Holm IE, Troost D, Hatanpaa KJ et al (2007) TDP-43 in familial and sporadic frontotemporal lobar degeneration with ubiquitin inclusions. Am J Pathol 171 : 227 240. (Pubitemid 47342406)
8. Ciechanover A (2006) The ubiquitin proteolytic system: from a vague idea, through basic mechanisms, and onto human diseases and drug targeting. Neurology 66 : S7 S19.
9. Davidson Y, Kelley T, Mackenzie IR, Pickering-Brown S, Du Plessis D, Neary D et al (2007) Ubiquitinated pathological lesions in frontotemporal lobar degeneration contain the TAR DNA-binding protein, TDP-43. Acta Neuropathol 113 : 521 533.
10. Dickson DW, Liu W-K, Hardy J, Farrer M, Metha N, Uitti R et al (1999) Widespread alterations of α-synuclein in multiple system atrophy. Am J Pathol 155 : 1241 1251.
11. Dickson DW, Joseph KA, Amador Ortiz C (2007) TDP-43 in differential diagnosis of motor neuron disorders. Acta Neuropathol 114 : 71 79.
12. Fujita Y, Mizuno Y, Takamata M, Okamoto K (2008) Anterior horn cells with abnormal TDP-43 immunoreactivities show fragmentation of the Golgi apparatus in ALS. J Neurol Sci 269 : 30 34.
13. Gitcho MA, Baloh RH, Chakraverty S, Mayo K, Norton JB, Levitch D et al (2008) TDP-43 A315T mutation in familial motor neuron disease. Ann Neurol 63 : 535 538.
14. Glickman MH, Ciechanover A (2002) The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction. Physiol Rev 82 : 373 428.
15. Hasegawa M, Arai T, Akiyama H, Nonaka T, Mori H, Hashimoto T et al (2007) TDP-43 is deposited in the Guam parkinsonism-dementia complex brains. Brain 130 : 1386 1394.
16. Hasegawa M, Arai T, Nonaka T, Kametani F, Yoshida M, Hashizume Y et al (2008) Phosphorylated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Ann Neurol 64 : 60 70.
17. Igaz LM, Kwong LK, Xu Y, Truax AC, Uryu K, Neumann M et al (2008) Enrichment of C-terminal fragments in TAR DNA-binding protein-43 cytoplasmic inclusions in brain but not in spinal cord of frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Am J Pathol 173 : 182 194.
18. Kabashi E, Valdmanis PN, Dion P, Spiegelman D, McConkey BJ, Vande Velde C et al (2008) TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis. Nat Genet 40 : 572 574.
19. Kisselev AF, Goldberg AL (2001) Proteasome inhibitors: from research tools to drug candidates. Chem Biol 8 : 739 758.
20. Kwong LK, Neumann M, Sampathu DM, Lee VM, Trojanowski JQ (2007) TDP-43 proteinopathy: the neuropathology underlying major forms of sporadic and familial frontotemporal lobar degeneration and motor neuron disease. Acta Neuropathol 114 : 63 70.
21. Leigh PN, Whitwell H, Garofalo O, Buller J, Swash M, Martin JE et al (1991) Ubiquitin-immunoreactive intraneuronal inclusions in amyotrophic lateral sclerosis. Morphology, distribution and specificity. Brain 114 : 775 788.
22. Lomen-Hoerth C (2004) Characterization of amyotrophic lateral sclerosis and frontotemporal dementia. Dement Geriatr Cogn Disord 17 : 337 341.
23. Mackenzie IR, Bigio EH, Ince PG, Geser F, Neumann M, Cairns NJ et al (2007) Pathological TDP-43 distinguishes sporadic amyotrophic lateral sclerosis from amyotrophic lateral sclerosis with SOD1 mutations. Ann Neurol 61 : 427 434.
24. Mackenzie IRA, Feldman H (2005) Ubiquitin immunohistochemistry suggests classic motor neuron disease, motor neuron disease with dementia and frontotemporal dementia of the motor neuron disease type represent a clinicopathologic spectrum. J Neuropathol Exp Neurol 64 : 730 739.
25. Matunis MJ (2006) Isolation and fractionation of rat liver nuclear envelopes and nuclear pore complexes. Methods 39 : 277 283.
26. Mercado PA, Ayala YM, Romano M, Buratti E, Baralle FE (2005) Depletion of TDP-43 overrides the need for exonic and intronic splicing enhancers in the human apoA-II gene. Nucleic Acids Res 33 : 6000 6010.
27. Mori F, Tanji K, Zhang HX, Nishihira Y, Tan CF, Takahashi H, Wakabayashi K (2008) Maturation process of TDP-43-positive neuronal cytoplasmic inclusions in amyotrophic lateral sclerosis with and without dementia. Acta Neuropathol 116 : 193 203.
28. Neary D, Snowden JS, Gustafson L, Passant U, Stuss D, Black S et al (1998) Frontotemporal lobar degeneration. A consensus on clinical diagnostic criteria. Neurology 51 : 1546 1554.
29. Neumann M, Sampathu DM, Kwong LK, Truax AC, Micsenyi MC, Chou TT et al (2006) Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 314 : 130 133.
30. Pasinelli P, Brown RH (2006) Molecular biology of amyotrophic lateral sclerosis: insights from genetics. Nat Rev Neurosci 7 : 710 723.
31. Princiotta MF, Schubert U, Chen W, Bennink JR, Myung J, Crews CM, Yewdell JW (2001) Cells adapted to the proteasome inhibitor 4-hydroxy-5-iodo-3- nitrophenylacetyl-Leu-Leu-leucinal-vivyl sulfone require enzymatically active proteasomes for continued survival. Proc Natl Acad Sci USA 98 : 513 518.
32. Robertson J, Sanelli T, Xiao S, Yang W, Horne P, Hammond R et al (2007) Lack of TDP-43 abnormalities in mutant SOD1 transgenic mice shows disparity with ALS. Neurosci Lett 420 : 128 132.
33. Sanelli T, Xiao S, Horne P, Bilbao J, Zinman L, Robertson J (2007) Evidence that TDP-43 is not the major ubiquitinated target within the pathological inclusions of amyotrophic lateral sclerosis. J Neuropathol Exp Neurol 66 : 1147 1153.
34. Schiffer D, Autilio-Gambetti L, Chiò A, Gambetti P, Giordana MT, Gullotta F et al (1991) Ubiquitin in motor neuron disease: study at the light and electron microscope. J Neuropathol Exp Neurol 50 : 463 473.
35. Sreedharan J, Blair IP, Tripathi VB, Hu X, Vance C, Rogelj B et al (2008) TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis. Science 319 : 1668 1670.
36. Strong MJ, Volkening K, Hammond R, Yang W, Strong W, Leystra-Lantz C, Shoesmith C (2007) TDP-43 is a human low molecular weight neurofilament (hNFL) mRNA-binding protein. Mol Cell Neurosci 35 : 320 327. (Pubitemid 46843567)
37. Tan CF, Eguchi H, Tagawa A, Onodera O, Iwasaki T, Tsujino A et al (2007) TDP-43 immunoreactivity in neuronal inclusions in familial amyotrophic lateral sclerosis with or without SOD1 gene mutation. Acta Neuropathol 113 : 535 542.
38. Tata JR (1974) Isolation of nuclei from liver and other tissues. Methods Enzymol 31 (Pt A 253 262.
39. Taylor CM, Coetzee T, Pfeiffer SE (2002) Detergent-insoluble glycosphingolipid/cholesterol microdomains of the myelin membrane. J Neurochem 81 : 993 1004.
40. Van Deerlin VM, Leverenz JB, Bekris LM, Bird TD, Yuan W, Elman LB et al (2008) TARDBP mutations in amyotrophic lateral sclerosis with TDP-43 neuropathology: a genetic and histopathological analysis. Lancet Neurol 7 : 409 416.
41. Winton MJ, Igaz LM, Wong MM, Kwong LK, Trojanowski JQ, Lee VM (2008) Disturbances of nuclear and cytoplasmic TAR DNA binding protein (TDP-43) induces disease-like redistribution, sequestration and aggregate formation. J Biol Chem 283 : 13302 13309.
42. Yokoseki A, Shiga A, Tan CF, Tagawa A, Kaneko H, Koyama A et al (2008) TDP-43 mutation in familial amyotrophic lateral sclerosis. Ann Neurol 63 : 538 542.